Literature DB >> 10713009

Mortality from primary pulmonary hypertension in the United States, 1979-1996.

D E Lilienfeld1, L J Rubin.   

Abstract

STUDY
OBJECTIVES: To determine whether primary pulmonary hypertension mortality in the United States increased since 1979 coincident with the introduction of anorexigens.
DESIGN: Examination of annual age-adjusted and age-specific primary pulmonary hypertension mortality in the United States from 1979 through 1996 and in five selected states from 1992 through 1996.
SETTING: The United States, from 1979 through 1996. PATIENTS OR PARTICIPANTS: Residents of the United States, from 1979 through 1996.
INTERVENTIONS: None. MEASUREMENTS AND
RESULTS: Annual age-adjusted mortality increased at different rates among white men and women and black men and women. The greatest increase was among black women (who also had the highest rates). Age-specific mortality showed a high rate among infants < 1 year old, a low rate in childhood, and an ascending rate throughout the remainder of life. Similar patterns were identified at the state level.
CONCLUSIONS: Primary pulmonary hypertension mortality in the United States has increased notably since 1979. Some portion of this increase may be related to the introduction of anorexigens. Improvements in diagnostic recognition may also explain part of the increase in mortality. These results need to be confirmed in a diagnosis validation study, particularly because the same mortality data suggest that the disease may be more common in the elderly than has been previously reported.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10713009     DOI: 10.1378/chest.117.3.796

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  17 in total

1.  Rapid regression of primary pulmonary hypertension.

Authors:  C J McMahon; J Kadkin; M R Nihill
Journal:  Heart       Date:  2001-07       Impact factor: 5.994

2.  International Classification of Diseases coding changes lead to profound declines in reported idiopathic pulmonary arterial hypertension mortality and hospitalizations: implications for database studies.

Authors:  Jeffrey Link; Craig Glazer; Fernando Torres; Kelly Chin
Journal:  Chest       Date:  2010-08-19       Impact factor: 9.410

Review 3.  Pulmonary arterial hypertension.

Authors:  Aydin Uzunpinar; Mehmet Cilingiroglu
Journal:  Curr Atheroscler Rep       Date:  2009-03       Impact factor: 5.113

4.  Racial and Ethnic Differences in Pediatric Pulmonary Hypertension: An Analysis of the Pediatric Pulmonary Hypertension Network Registry.

Authors:  Mei-Sing Ong; Steve Abman; Eric D Austin; Jeffrey A Feinstein; Rachel K Hopper; Usha S Krishnan; Mary P Mullen; Marc D Natter; J Usha Raj; Erika B Rosenzweig; Kenneth D Mandl
Journal:  J Pediatr       Date:  2019-06-05       Impact factor: 4.406

5.  Mortality from pulmonary heart disease in Japan, 1979-2006.

Authors:  Masahito Sakuma; Norifumi Nakanishi; Kunio Shirato
Journal:  Ann Vasc Dis       Date:  2010-11-10

Review 6.  Safety of drug therapies used for weight loss and treatment of obesity.

Authors:  Lisa L Ioannides-Demos; Joseph Proietto; Andrew M Tonkin; John J McNeil
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

7.  The PPARγ ligand rosiglitazone attenuates hypoxia-induced endothelin signaling in vitro and in vivo.

Authors:  Bum-Yong Kang; Jennifer M Kleinhenz; Tamara C Murphy; C Michael Hart
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-09-16       Impact factor: 5.464

8.  Genetic Admixture and Survival in Diverse Populations with Pulmonary Arterial Hypertension.

Authors:  Jason H Karnes; Howard W Wiener; Tae-Hwi Schwantes-An; Balaji Natarajan; Andrew J Sweatt; Abhishek Chaturvedi; Amit Arora; Ken Batai; Vineet Nair; Heidi E Steiner; Jason B Giles; Jeffrey Yu; Maryam Hosseini; Michael W Pauciulo; Katie A Lutz; Anna W Coleman; Jeremy Feldman; Rebecca Vanderpool; Haiyang Tang; Joe G N Garcia; Jason X-J Yuan; Rick Kittles; Vinicio de Jesus Perez; Roham T Zamanian; Franz Rischard; Hemant K Tiwari; William C Nichols; Raymond L Benza; Ankit A Desai
Journal:  Am J Respir Crit Care Med       Date:  2020-06-01       Impact factor: 21.405

9.  Peroxisome Proliferator-Activated Receptor γ Regulates the V-Ets Avian Erythroblastosis Virus E26 Oncogene Homolog 1/microRNA-27a Axis to Reduce Endothelin-1 and Endothelial Dysfunction in the Sickle Cell Mouse Lung.

Authors:  Bum-Yong Kang; Kathy Park; Jennifer M Kleinhenz; Tamara C Murphy; Roy L Sutliff; David Archer; C Michael Hart
Journal:  Am J Respir Cell Mol Biol       Date:  2017-01       Impact factor: 6.914

10.  Protective effects of hydroalcoholic extract from rhizomes of Cynodon dactylon (L.) Pers. on compensated right heart failure in rats.

Authors:  Alireza Garjani; Arash Afrooziyan; Hossein Nazemiyeh; Moslem Najafi; Ali Kharazmkia; Nasrin Maleki-Dizaji
Journal:  BMC Complement Altern Med       Date:  2009-08-05       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.